Document Detail


Increased spinal dynorphin levels and phospho-extracellular signal-regulated kinases 1 and 2 and c-Fos immunoreactivity after surgery under remifentanil anesthesia in mice.
MedLine Citation:
PMID:  19917879     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In humans, remifentanil anesthesia enhances nociceptive sensitization in the postoperative period. We hypothesized that activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and the expression of c-Fos, prodynorphin (mRNA), and dynorphin in the spinal cord could participate in the molecular mechanisms underlying postoperative opioid-induced sensitization. In a mouse model of incisional pain, we evaluated thermal (Hargreaves test) and mechanical (von Frey) hyperalgesia during the first 21 postoperative days. Moreover, prodynorphin (mRNA, real-time polymerase chain reaction), dynorphin (enzymatic immunoassay), c-Fos expression, and ERK1/2 phosphorylation (both by immunohistochemistry) in the lumbar spinal cord were assessed. Surgery performed under remifentanil anesthesia induced a maximal decrease in nociceptive thresholds between 4 h and 2 days postoperatively (p < 0.001) that lasted 10 to 14 days compared with noninjured animals. In the same experimental conditions, a significant increase in prodynorphin mRNA expression (at 2 and 4 days) followed by a sustained increase of dynorphin (days 2 to 10) in the spinal cord was observed. We also identified an early expression of c-Fos immunoreactivity in the superficial laminae of the dorsal horn of the spinal cord (peak at 4 h; p < 0.001), together with a partial activation of ERK1/2 (4 h; p < 0.001). These findings suggest that activated ERK1/2 could induce c-Fos expression and trigger the transcription of prodynorphin in the spinal cord. This in turn would result in long-lasting increased levels of dynorphin that, in our model, could participate in the persistence of pain but not in the manifestation of first pain.
Authors:
Ana Campillo; Ana Gonz?lez-Cuello; David Caba?ero; Paula Garcia-Nogales; Asunci?n Romero; M Victoria Milan?s; M Luisa Laorden; Margarita M Puig
Related Documents :
18802749 - Peripheral nerve injury induces down-regulation of foxo3a and p27kip1 in rat dorsal roo...
18941509 - A novel function of ring finger protein 10 in transcriptional regulation of the myelin-...
20816819 - Cycling exercise affects the expression of apoptosis-associated micrornas after spinal ...
20860549 - Traumatic spinal cord injury alters angiogenic factors and tgf-beta1 that may affect va...
18000829 - Otoc1: a novel otoconin-90 ortholog required for otolith mineralization in zebrafish.
14516669 - Novel sites of expression of the bhlh gene nscl1 in the developing nervous system.
12656669 - Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
19203999 - Calcineurin activates cytoglobin transcription in hypoxic myocytes.
9030699 - Expression of the orphan receptor steroidogenic factor-1 mrna in the rat medial basal h...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-16
Journal Detail:
Title:  Molecular pharmacology     Volume:  77     ISSN:  1521-0111     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-20     Completed Date:  2010-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  185-94     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, Hospital Universitari del Mar, Universitat Aut?noma de Barcelona, Passeig Mar?tim 25-29, E-08003 Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Intravenous / pharmacology,  therapeutic use
Animals
Dynorphins / biosynthesis*
Genes, fos / physiology*
Male
Mice
Mitogen-Activated Protein Kinase 1 / biosynthesis*
Mitogen-Activated Protein Kinase 3 / biosynthesis*
Pain Measurement / drug effects,  methods
Pain, Postoperative / metabolism*,  prevention & control
Piperidines / pharmacology,  therapeutic use*
Spinal Cord / drug effects,  metabolism
Chemical
Reg. No./Substance:
0/Anesthetics, Intravenous; 0/Piperidines; 132875-61-7/remifentanil; 74913-18-1/Dynorphins; EC 2.7.11.24/Mitogen-Activated Protein Kinase 1; EC 2.7.11.24/Mitogen-Activated Protein Kinase 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there a future for HDAC inhibitors in the pharmacotherapy of psychiatric disorders?
Next Document:  The AHR regulates cell cycle progression in human breast cancer cells via a functional interaction w...